GEORGE EDWARD WOODY
Affiliation: Treatment Research Institute
- Antagonist Models for Relapse Prevention and Reducing HIV RiskGeorge E Woody
Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, 3440 Market Street Suite 370, Philadelphia, PA, 19104, USA
J Neuroimmune Pharmacol 11:401-7. 2016....
- Antagonist models for treating persons with substance use disordersGeorge E Woody
Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Treatment Research Institute, 150 South Independence Mall W, Philadelphia, PA, 19106, USA
Curr Psychiatry Rep 16:489. 2014..Vaccines are a very interesting and promising new development but many challenges and hurdles must be overcome before they are ready for clinical use. ..
- Predictors and moderators of outcomes of HIV/STD sex risk reduction interventions in substance abuse treatment programs: a pooled analysis of two randomized controlled trialsPaul Crits-Christoph
Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
Subst Abuse Treat Prev Policy 9:3. 2014..The objective of the current study was to examine predictors and moderators of response to two HIV sexual risk interventions of different content and duration for individuals in substance abuse treatment programs...
- Overcoming opioid blockade from depot naltrexone (Prodetoxon)E M Kruptisky
St Petersburg Regional Center in Addiction and Psychopharmacology affiliated with Pavlov State Medical University, St Petersburg, Russia
Addiction 102:1164-5. 2007..To describe a situation in which an opioid-dependent patient overcame naltrexone blockade. DESIGN, CASE REPORT, SETTING: Addiction treatment center in St Petersburg, Russia...
- Early data from Project Engage: a program to identify and transition medically hospitalized patients into addictions treatmentAnna Pecoraro
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Addict Sci Clin Pract 7:20. 2012..This program evaluation provides descriptive information on self-reported rates of SUD treatment initiation of all patients and health-care utilization and costs for a subset of patients...
- Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trialGeorge E Woody
Department of Psychiatry, Treatment Research Institute, University of Pennsylvania, 150 S Independence Mall W, Ste 600, Philadelphia, PA 19106, USA
JAMA 300:2003-11. 2008..The usual treatment for opioid-addicted youth is detoxification and counseling. Extended medication-assisted therapy may be more helpful...
- Substance use among men who have sex with men: comparison with a national household surveyG E Woody
University of Pennsylvania Philadelphia Veterans Affairs Medical Center, USA
J Acquir Immune Defic Syndr 27:86-90. 2001..Compare substance use among men who have sex with men (MSM) at high risk for HIV infection to a nationally representative sample of heterosexual men...
- An independent assessment of MEDWatch reporting for abuse/dependence and withdrawal from Ultram (tramadol hydrochloride)George E Woody
Treatment Research Institute, School of Medicine, Philadelphia Va University of Pennsylvania, 600 Public Ledger Building, 150 South Independence Mall W, Philadelphia, PA 19106 3475, USA
Drug Alcohol Depend 72:163-8. 2003..Assess the validity of medical products reporting program (MEDWatch) reports of abuse/dependence and withdrawal associated with Ultram (tramadol)...
- HIV risk reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment StudyGeorge E Woody
University of Pennsylvania, Philadelphia, Pennsylvania 19106 3475, USA
J Acquir Immune Defic Syndr 33:82-7. 2003..The combination of IDC and GDC was associated with an equal or even greater reduction in HIV risk than the other treatment conditions and thus shows promise as an effective HIV prevention strategy, at least for some patients...
- Prescription OxyContin abuse among patients entering addiction treatmentDeni Carise
Treatment Systems Section, Treatment Research Institute, 600 Public Ledger Building, 150 South Independence Mall West, Philadelphia, PA 19106 3475, USA
Am J Psychiatry 164:1750-6. 2007..The purpose of this study was to characterize the nature and origins of pharmaceutical opioid addiction among patients presenting at substance abuse treatment programs...
- An item response theory modeling of alcohol and marijuana dependences: a National Drug Abuse Treatment Clinical Trials Network studyLi Tzy Wu
Department of Psychiatry and Behavioral Sciences, School of Medicine, Duke Clinical Research Institute, Duke University, Duke University Medical Center, Durham, North Carolina 27710, USA
J Stud Alcohol Drugs 70:414-25. 2009....
- Using a latent variable approach to inform gender and racial/ethnic differences in cocaine dependence: a National Drug Abuse Treatment Clinical Trials Network studyLi Tzy Wu
Department of Psychiatry and Behavioral Sciences, School of Medicine, Duke University Medical Center, Duke Clinical Research Institute, Durham, NC 27710, USA
J Subst Abuse Treat 38:S70-9. 2010....
- Drug treatment as HIV prevention: a research updateDavid S Metzger
HIV AIDS Prevention Research Division, University of Pennsylvania, Philadelphia, PA 19104, USA
J Acquir Immune Defic Syndr 55:S32-6. 2010..Although there are challenges to implementing drug treatment programs for maximum impact, the scientific literature leaves no doubt about the effectiveness of drug treatment as an HIV prevention strategy...
- Research findings on psychotherapy of addictive disordersGeorge E Woody
Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19106, USA
Am J Addict 12:S19-26. 2003..Major studies of psychotherapy in the treatment of addictive disorders are reviewed, and background information on psychotherapy and drug counseling is presented...
- MET meets the real world: design issues and clinical strategies in the Clinical Trials NetworkKathleen M Carroll
Department of Psychiatry, Yale University School of Medicine, West Haven, CT 06516, USA
J Subst Abuse Treat 23:73-80. 2002..Issues requiring attention included the diversity in treatments offered across sites, heterogeneity in the study sample, and training of clinicians drawn from the staff of community programs to deliver the study treatments...
- Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to actionCHARLES P O'BRIEN
Department of Psychiatry, University of Pennsylvania School of Medicine, 3900 Chestnut Street, Philadelphia, PA 19104 6178, USA
Biol Psychiatry 56:703-13. 2004
- Penn/VA center for studies of addictionCHARLES P O'BRIEN
University of Pennsylvania, Treatment Research Center, 3900 Chestnut Street, Philadelphia, PA 19104 6178, USA
Neuropharmacology 56:44-7. 2009..Some of the findings that came out of both the Penn/VA laboratory and clinical studies are now widely accepted and form the basis of standard clinical practice. These concepts and evidence will be briefly reviewed below...
- Site matters: multisite randomized trial of motivational enhancement therapy in community drug abuse clinicsSamuel A Ball
Department of Psychiatry, Yale University School of Medicine, APT Foundation, New Haven, CT 06511, USA
J Consult Clin Psychol 75:556-67. 2007..An independent evaluation of session audiotapes indicated that MET and CAU were highly and comparably discriminable across sites...
- Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness studyKathleen M Carroll
Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, 950 Campbell Avenue, West Haven, CT 06516, USA
Drug Alcohol Depend 81:301-12. 2006....
- The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS)Theodore J Cicero
Washington University School of Medicine, St Louis, Missouri 63110, USA
Pain Med 8:157-70. 2007..Thus, its major focus was the detection of abuse of OxyContin and other commonly prescribed opioid analgesics at the three-digit ZIP code level across the country utilizing a number of different detection systems...
- Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004Theodore J Cicero
Washington University School of Medicine, 660 South Euclid Avenue, St Louis, MO 63110, USA
Pharmacoepidemiol Drug Saf 14:851-9. 2005..This provided a unique opportunity to study the potential changes in abuse as the generic and combination products became available...
- Preliminary estimates of human immunodeficiency virus prevalence and incidence among cocaine abusers of Porto Alegre, BrazilFlavio Pechansky
Research Group of Drug Abuse, Department of Psychiatry, Federal University of Rio Grande do Sul, Brazil
J Urban Health 80:115-26. 2003..Each of these findings has important implications for the design of preventive interventions...
- Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occurEdward C Senay
Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, USA
Drug Alcohol Depend 69:233-41. 2003..These results indicate that physicians and other healthcare professionals need to be aware of the potential of Ultram to induce withdrawal of the classical opioid type, and that atypical withdrawal may also occur...
- A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic painEdgar H Adams
Edgar Adams Consulting, Covance, Princeton, New Jersey 08540, USA
J Pain Symptom Manage 31:465-76. 2006....
- The Diversion of Ultram, Ultracet, and generic tramadol HCLJames A Inciardi
University of Delaware Research Center, Coral Gables, FL 33134, USA
J Addict Dis 25:53-8. 2006..Survey data suggest that the diversion of Ultram and other tramadol products is low, and overall, diversion investigators did not consider tramadol to be a problem in their respective jurisdictions...
- The availability of web sites offering to sell opioid medications without prescriptionsRobert F Forman
Medical Affairs Alkermes, Inc, 88 Sidney St, Cambridge, MA 02139, USA
Am J Psychiatry 163:1233-8. 2006..This study was designed to determine the availability of web sites offering to sell opioid medications without prescriptions...
- Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, RussiaEvgeny M Krupitsky
St Petersburg Scientific Research Center of Addictions and Psychopharmacology, St Petersburg, Russia
J Subst Abuse Treat 31:319-28. 2006..More widespread use of naltrexone could be an important addition to addiction treatment and HIV prevention in Russia...
- Buprenorphine use: the international experienceMaria Patrizia Carrieri
INSERM U379, Marseilles, France
Clin Infect Dis 43:S197-215. 2006....
- Errors in assessing DSM-IV substance use disordersBridget F Grant
Arch Gen Psychiatry 64:379-80; author reply 381-2. 2007
- New horizons: sustained release morphine as agonist treatmentGeorge E Woody
Addiction 100:1758-9. 2005
- Abuse of buprenorphine in the United States: 2003-2005Meredith Y Smith
Risk Management and Health Policy, Purdue Pharma L P, Stamford, CT 06901 3431, USA
J Addict Dis 26:107-11. 2007..08 (SD +/- 0.09) for Subutex, and 0.16 (SD +/- 0.08) for Suboxone. Findings suggest that these sublingual buprenorphine formulations have a low rate of abuse based on toxico-surveillance data...
- Naltrexone for heroin dependence treatment in St. Petersburg, RussiaEvgeny M Krupitsky
St Petersburg Scientific Research Center of Addictions and Psychopharmacology, affiliated with St Petersburg State Pavlov Medical University, Russia
J Subst Abuse Treat 26:285-94. 2004..05). Since heroin dependence is the main way HIV is being spread in Russia, naltrexone is likely to improve treatment outcome and help reduce the spread of HIV if it can be made more widely available...
- Implications of cannabis use and heavy alcohol use on HIV drug risk behaviors in Russian heroin usersAlexander Y Walley
Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston Medical Center and Boston University School of Medicine, 91 E Concord St, Suite 200, Boston, MA 02118, USA
AIDS Behav 12:662-9. 2008..1 points). Because of the central role of risky drug behaviors in the Russian HIV epidemic, it is important to understand how the use of multiple substances, including cannabis and alcohol, impacts risky drug behaviors...
- PERSISTENT EFFECTS OF LT/LI DRUG RISK COUNSELINGGeorge Woody; Fiscal Year: 2002..We also believe this model of intervention has important public health significance as a sustainable, community based, early intervention for drug users. ..
- Addiction Treatment in Russia: Oral and Depot NaltrexoneGeorge Woody; Fiscal Year: 2007..We hypothesize that outcomes will be better with DIN than ON, and that each will be more effective than placebo. ..
- Methadone maintenance and HIV risk in UkraineGeorge Woody; Fiscal Year: 2007..unreadable] [unreadable]..